Study Suggests Bempedoic Acid Could Find Role in Primary Prevention
An analysis of a primary prevention subgroup within the CLEAR Outcomes trial presented at ADA 2023 suggests use of bempedoic acid was associated with a 30% relative risk reduction for MACE among this patient population.
Source: hcplive.com